Pfizer to seek regulatory approval within days as vaccine proves 95% effective
US drugmaker and partner BioNTech say vaccine protected people of all ages and ethnicities, with no significant safety problems in trials
18 November 2020 - 17:52
Pfizer said on Wednesday a final analysis of clinical-trial data showed its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first US regulatory authorisation for a coronavirus shot within days.
The US drugmaker and partner BioNTech said their vaccine protected people of all ages and ethnicities, with no significant safety problems so far in a trial that includes almost 44,000 participants...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.